AI diagnosis of B6 deficiency saves UK Parkinson’s patient from fatal seizures

Key points

• Ann Patrick, in her late 70s, suffered continuous seizures and developed rhabdomyolysis, a condition where muscle breakdown releases toxins into the bloodstream, potentially damaging kidneys.
• Despite multiple doctors and tests, including negative CT and MRI scans, the cause of her seizures remained unexplained for months.
• Edward Patrick entered his mother’s symptoms and medical data into an AI tool, which suggested a vitamin B6 deficiency linked to her Parkinson’s medication.
• The medical team at Queen’s Medical Centre in Nottingham administered intravenous vitamin B6, which immediately stopped the seizures.
• Ann Patrick has since shown significant improvement and has not required further hospital admissions.

Background

This incident follows earlier reports in October 2026 highlighting AI’s potential in clinical diagnosis, particularly in identifying rare nutrient deficiencies linked to chronic medications. Previous coverage noted that while AI can offer rapid insights, experts emphasize the need for formal trials to validate such connections, especially regarding Parkinson’s drugs and B6 deficiency.

How outlets are covering it

Hindustan Times and NDTV both highlight the dramatic 'House moment' comparison, emphasizing the AI’s role in solving a mystery that traditional medicine missed. The Times of India focuses on the collaborative effort between Edward and his brother, who first suggested the vitamin deficiency. All sources agree on the outcome but differ in emphasis: Hindustan Times and NDTV stress the AI’s diagnostic power, while The Times of India highlights the human element and the brother’s initial insight. No source disputes the medical outcome, but they vary in how they frame the AI’s reliability versus human intuition.

Why it matters

This case illustrates the growing role of AI in bridging gaps in medical diagnosis, particularly for rare or complex conditions. It raises questions about the integration of AI tools in clinical settings and the potential for AI to assist in identifying overlooked causes of severe symptoms, such as nutrient deficiencies linked to long-term medications.

What to watch

Medical experts may use this case to advocate for broader AI integration in diagnostic processes, though caution remains about over-reliance without formal validation. Ann Patrick’s recovery may lead to further research into the link between Parkinson’s medications and B6 deficiency, potentially influencing future treatment protocols.